Key Takeaways:
- The EAEU has extended the transition period for unified medical device registration until 31 December 2027.
- Member states may submit registration applications under union law or national law until the deadline, delaying full union-only registration until 2028.
- The extension aims to give states time to harmonise national systems and ensure a smoother shift to the EAEU unified medical device registration.
Moscow, 30 December — The member states of the Eurasian Economic Union (EAEU) have agreed to extend the transition period for adopting a single registration system for medical devices until the end of 2027, the Eurasian Economic Commission said on Tuesday.
The protocol amends the agreement on common principles and rules governing the circulation of medical devices within the union. It allows companies and regulators to submit applications for expert review and national registration under either EAEU law or the legislation of individual member states until 31 December 2027. Previously, that option was due to expire on 31 December 2025, with the expectation that from 1 January 2026 registration would be carried out solely under union law.
EAEU unified medical device registration timeline
Under the revised timeline, the protocol will be provisionally applied 10 days after signing and will come into force once the Commission receives the final written notification that all member states have completed required domestic procedures. The extension effectively postpones the point at which the EAEU’s single regulatory framework becomes the exclusive route for registering medical devices.
Officials at the Eurasian Economic Commission said the measure is intended to give member states additional time to optimise and harmonise their national registration systems. By allowing a two-stage transition, regulators can complete remaining national registration procedures while preparing domestic agencies and industry for the shift to common union rules.
Manufacturers and distributors of medical devices in the EAEU will be able to decide whether to continue using national registration routes or seek approval under the union regime during the extended period. The move is likely to reduce disruption for companies that require more time to meet new technical requirements, documentation standards and administrative processes under the EAEU framework.
Industry observers said the extension could ease pressure on national competent authorities and testing laboratories, which have faced a tight deadline to build capacity and align regulatory practices. The extra two years will also allow stakeholders to pilot procedures under the union rules and address any legal or technical inconsistencies before the transition completes.
For patients and healthcare providers, a harmonised registration system promises clearer standards and potentially more consistent oversight of medical devices across the union. However, the benefits depend on effective implementation, continued cooperation between member states and timely completion of the remaining national formalities.
The protocol’s temporary application provision means parts of the agreement may start operating before formal entry into force, reducing gaps in regulation while member states finalise internal approvals. The Commission will announce when it receives the last notification from a member state, at which point the protocol will take full effect.
By extending the deadline to 31 December 2027, the EAEU seeks to strike a balance between speeding up regional regulatory convergence and recognising practical constraints within national systems. The additional time aims to foster a smoother transition to the EAEU unified medical device registration and to limit disruption for manufacturers, regulators and healthcare systems across the union.
